medline.ch Onkologie Gynäkologische Tumoren

	Availability and public reimbursement of early breast cancer care across European expert centres: a PORTRAIT from an EUSOMA initiative. Breast Bonci EA, Di Micco R, Marotti L, Miraldo M, Rubio IT, Curigliano G, Cardoso MJ, PORTRAIT Study Group. PMID: 42447838 [PubMed - as supplied by publisher]
	CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study. J Geriatr Oncol Schiza A, Fountzilas E, Biganzoli L, Digkas E, Fjermeros K, Geisler J, Karihtala P, Lindman H, Meattini I, Munoz-Mateu M, Risi E, Spathas N, Utriainen M, Visani L, Valachis A, Othman M. PMID: 42447829 [PubMed - as supplied by publisher]
	Efficacy of doxorubicin-loaded graphene nanoplatform chemo-photothermal therapy versus photothermal therapy alone for breast cancer xenograft tumors: a meta-analysis. Int J Hyperthermia Gao HW, Li ZH, Lu Y, Fang YG, Shen FF, Song LW, Yu FZ. PMID: 42449201 [PubMed - in process]
	Neoadjuvant immunotherapy in breast cancer: Progress and challenges. Trends Cancer de Graaf M, De Caluwé A, Buisseret L, Kok M. PMID: 42448554 [PubMed - as supplied by publisher]
	Artificial Intelligence-Based Computer-Aided Detection in Breast Cancer Diagnosis: Variation by Breast Density, Imaging Feature, and Tumor Characteristics. Acad Radiol Eugene N, Parghi C, Elabeid J, Pantleo J, Gonzalez N, Sharma A, Zhang Z. PMID: 42448486 [PubMed - as supplied by publisher]
	Feasibility, Usability, and Preliminary Effectiveness of an mHealth App to Promote Screening Behaviors Among High-Risk Populations for Breast Cancer: Randomized Controlled Pilot Study. JMIR Mhealth Uhealth Zhang L, Xu M, Zhang X, Li X, Wang S, Zhou F, Han J. PMID: 42447462 [PubMed - in process]
	Efficacy evaluation of novel targeted drugs in patients with human epidermal growth factor receptor 2-positive breast cancer: A meta-analysis based on multiple sets of clinical data. J Int Med Res Lan Y, Wang R, Liu S. PMID: 42447291 [PubMed - in process]
	Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer. JAMA Netw Open Farolfi A, Casadei C, Scarpi E, Paoletti E, Gianni C, Palleschi M, Gentili N, Mariotti M, Testoni S, Di Menna G, Rusconi F, Andalò A, Serra O, Merloni F, Sirico M, Maltoni R, Cecconetto L, Sarti S, Musolino A. PMID: 42446878 [PubMed - indexed for MEDLINE]
	Educational, Racial, and Geographic Inequalities in Breast Cancer Screening and Diagnosis among Brazilian Women. J Racial Ethn Health Disparities Santana FG, de Branco FMS, Cunha KS, Rezende LFM, Azeredo CM. PMID: 42446866 [PubMed - as supplied by publisher]
	Real-world clinical outcomes of intermediate-risk PAM50 (i-ROR) in HR+/HER2- early breast cancer and eligibility for adjuvant CDK4/6 inhibitors. Breast Cancer Res Treat Terán S, Illia M, Quevedo MC, Moreno ML, Bianchi MA, Lema L, González C, Tolosa P, Madariaga A, Manso L, Ruano Y, Parrilla L, Cobos MÁ, Ciruelos E, Sánchez-Bayona R. PMID: 42446834 [PubMed - indexed for MEDLINE]
	lncRNA MEG3 and Beclin-1 as diagnostic biomarkers in serous ovarian carcinoma: molecular and immunohistochemical insights. J Mol Histol El Desoky AMZ, Abdelgeleel HM, Moustafa M, Abdalrahman MAM, Eldaly MM. PMID: 42446766 [PubMed - indexed for MEDLINE]
	Advances in quercetin-based therapeutics for breast cancer: natural, synthetic, and nanotechnology-driven approaches. Med Chem Res Shagufta, Ahmad I, Bazbouz LZ, Eissa AW, Abdellatif S. PMID: 42446692 [PubMed - indexed for MEDLINE]
	Civic engagement and breast cancer screening participation among US citizens. Cancer Baeker Bispo J, Lee H, Tian J, Jemal A, Islami F. PMID: 42446372 [PubMed - indexed for MEDLINE]
	Automation Bias in Action: Eye Tracking of Humans Reading Screening Mammograms with and without AI Prompts. Radiology Taib AG, Partridge GJW, Phillips P, Maxwell-Armstrong C, Chen X, Hofvind SSH, James JJ, Chen Y. PMID: 42446361 [PubMed - indexed for MEDLINE]
	The Dual Role of TLR2 in Breast Cancer: Implications for Therapeutic Targeting. Immunol Invest Yu H, Zhang Y, Du T, Zuo S. PMID: 42446204 [PubMed - as supplied by publisher]
	The Evolving Landscape of Deep Learning in Breast Cancer Imaging: A Bibliometric Study of Segmentation, Detection, and Diagnostic Research From 2006 to 2025. Cancer Control Zeng S, Wang L, Zhang Y, Deng Y, Shen X, Li Y. PMID: 42446135 [PubMed - indexed for MEDLINE]
	Gene expression profiling of ovarian cancer reveals candidate diagnostic and prognostic biomarkers: An integrated bioinformatics approach. Cancer Biomark Woode M, Appah MA, Alhassan EK, Makwo T, Asante DB, Agyirifo DS. PMID: 42445957 [PubMed - indexed for MEDLINE]
	Baculoviral Inhibitor of Apoptosis Repeat Containing 5 (BIRC5) Regulates Cancer Stem Cell Properties and Epithelial-Mesenchymal Transition in Human Breast Cancer Cells. Dev Reprod Jang JY, Kim RK. PMID: 42445845 [PubMed]
	A Preliminary Comparative Study on Clinical and Pathologic Response Patterns of Breast Cancer in Ghanaian Women Undergoing Neoadjuvant Chemotherapy and Hormonal Therapy. J West Afr Coll Surg Awoonor-Williams R, Abaidoo CS, Adjei E, Kyei I, Aitpillah F, Boakye E, Amankwaa-Frempong E, Yorke J, Darko ND, Diby TK, Boakye RA, Tetteh J, Appiah AK, Atobiga CN, Adjei-Antwi C, Nketsiah J, Sarkodie FK, Boakye-Yiadom J, Ansah EO. PMID: 42445763 [PubMed]
	Precision Endocrine-Based Combinations After CDK4/6 Inhibitor Progression in HR-Positive Metastatic Breast Cancer. Drug Des Devel Ther Abdel-Razeq H. PMID: 42445743 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 332115

Seite 1 von 16606

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung